[{"AccountsPayableCurrent_0_Q1_USD":3107000.0,"PreferredStockValueOutstanding_0_Q1_USD":0.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":18000.0,"PaymentsOfStockIssuanceCosts_1_Q1_USD":0.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-626000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":571000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":571000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":571000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":863000.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_1_Q1_USD":274000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":3008000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":1972000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":1085000.0,"OperatingLeaseExpense_1_Q1_USD":300000.0,"PrepaidExpenseCurrent_0_Q1_USD":5821000.0,"ProceedsFromContributedCapital_1_Q1_USD":91000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_1_Q1_USD":0.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":193000.0,"StockholdersEquity_0_Q1_USD":365532000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q1_USD":10.98,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1_Q1_USD":27.1,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q1_USD":14.01,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":6712189.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q1_USD":8142000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q1_USD":7.77,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":431980.0,"OperatingExpenses_1_Q1_USD":29886000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1_Q1_shares":1708790.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q1_shares":2130872.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q1_USD":4265000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q1_shares":7128692.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q1_pure":0.0,"ShareBasedCompensation_1_Q1_USD":3861000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-229128000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":18705000.0,"RelatedPartyTransactionAmountsOfTransaction_1_Q1_USD":100000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q1_USD":10.5,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":97976982.0,"NumberOfReportableSegments_1_Q1_segment":1.0,"NetIncomeLoss_1_Q1_USD":-30471000.0,"CommonStockSharesAuthorized_0_Q1_shares":500000000.0,"CommonStockNoParValue_0_Q1_USD":0.0001,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q1_shares":14782804.0,"CommitmentsAndContingencies_0_Q1_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-21141000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":379005000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":379005000.0,"AssetsCurrent_0_Q1_USD":384826000.0,"Assets_0_Q1_USD":388027000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":7654112.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":3820000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":3820000.0,"AdditionalPaidInCapital_0_Q1_USD":594377000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":273000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":1413000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":16331000.0,"AccruedBonusesCurrent_0_Q1_USD":1354000.0,"CommonStockSharesIssued_0_Q1_shares":97977595.0,"CommonStockSharesOutstanding_0_Q1_shares":97977595.0,"CommonStockValue_0_Q1_USD":10000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-29900000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-21214000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-18000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":91000.0,"LiabilitiesCurrent_0_Q1_USD":20523000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":388027000.0,"Liabilities_0_Q1_USD":22495000.0,"IncreaseDecreaseInPrepaidExpense_1_Q1_USD":-3039000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":1171000.0,"NumberOfOperatingSegments_1_Q1_segment":1.0,"IncreaseDecreaseInAccountsPayableTrade_1_Q1_USD":675000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q1_USD":-30512000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":11181000.0,"ForeignCurrencyTransactionGainLossUnrealized_1_Q1_USD":-571000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":0.0013,"EarningsPerShareDiluted_1_Q1_USD":-0.31,"EarningsPerShareBasic_1_Q1_USD":-0.31,"Depreciation_1_Q1_USD":26000.0,"ConvertiblePreferredStockSharesReservedForFutureIssuance_0_Q1_shares":10000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":-41000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":97976982.0,"Ticker":"IMVT","CIK":"1764013","name":"IMMUNOVANT, INC.","OfficialName":"Immunovant Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"407422400.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210809"}]